Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer. - de Heer, E. C.; Zois, C. E.; Bridges, E.; van der Vegt, B.; Sheldon, H.; Veldman, W. A.; Zwager, M. C.; van der Sluis, T.; Haider, S.; Morita, T.; Baba, O.; Schröder, C. P.; et al. (Journal of Experimental & Clinical Cancer Research (17569966), 2023)